[{"id":"93a94b53-4570-4860-a4f6-00aaaac1d92f","acronym":"MK-1775-001","url":"https://clinicaltrials.gov/study/NCT00648648","created_at":"2021-01-18T02:24:46.554Z","updated_at":"2024-07-02T16:35:36.517Z","phase":"Phase 1","brief_title":"A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)","source_id_and_acronym":"NCT00648648 - MK-1775-001","lead_sponsor":"Merck Sharp \u0026 Dohme LLC","biomarkers":" CDK1","pipe":"","alterations":" ","tags":["CDK1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • carboplatin • gemcitabine • adavosertib (AZD1775)"],"overall_status":"Completed","enrollment":" Enrollment 206","initiation":"Initiation: 02/25/2008","start_date":" 02/25/2008","primary_txt":" Primary completion: 01/06/2014","primary_completion_date":" 01/06/2014","study_txt":" Completion: 01/06/2014","study_completion_date":" 01/06/2014","last_update_posted":"2023-09-21"},{"id":"60c6440d-4895-4fff-9eb4-94c308053c49","acronym":"NCI-2022-03599","url":"https://clinicaltrials.gov/study/NCT05368506","created_at":"2022-05-10T19:53:37.209Z","updated_at":"2024-07-02T16:35:48.992Z","phase":"Phase 1","brief_title":"ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer","source_id_and_acronym":"NCT05368506 - NCI-2022-03599","lead_sponsor":"OHSU Knight Cancer Institute","biomarkers":" HER-2 • ER • PGR • CHEK1 • CDK1","pipe":"","alterations":" ","tags":["HER-2 • ER • PGR • CHEK1 • CDK1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e azenosertib (ZN-c3)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 07/30/2023","start_date":" 07/30/2023","primary_txt":" Primary completion: 09/30/2024","primary_completion_date":" 09/30/2024","study_txt":" Completion: 07/31/2025","study_completion_date":" 07/31/2025","last_update_posted":"2023-05-04"},{"id":"86997ced-5298-43a4-9224-06ed854047c2","acronym":"","url":"https://clinicaltrials.gov/study/NCT02207010","created_at":"2021-01-18T10:20:00.773Z","updated_at":"2024-07-02T16:36:37.524Z","phase":"Phase 1","brief_title":"A Phase 0 Study of AZD1775 in Recurrent GBM Patients","source_id_and_acronym":"NCT02207010","lead_sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","biomarkers":" CDK1","pipe":"","alterations":" ","tags":["CDK1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e adavosertib (AZD1775)"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 07/01/2014","start_date":" 07/01/2014","primary_txt":" Primary completion: 12/31/2015","primary_completion_date":" 12/31/2015","study_txt":" Completion: 03/25/2019","study_completion_date":" 03/25/2019","last_update_posted":"2020-12-10"}]